Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 7 Neoplasms 4 Glioblastoma 4 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rare Tumour 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Locally Advanced Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hereditary leiomyomatosis and renal cell cancer 1 HER2-negative Breast Cancer 1 Gliosarcoma 1 Glioma 1 For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinosarcoma 1

Interventions

Temozolomide 159 Bevacizumab 69 Radiotherapy 68 Magnetic Resonance Spectroscopy 68 Irinotecan 31 Surgical Procedures, Operative 27 Radiation 24 Carboplatin 23 Specimen Handling 20 Carmustine 20 Blood Specimen Collection 20 Nivolumab 19 Aminolevulinic Acid 18 Biopsy 17 Lomustine 16 pembrolizumab 13 Radiotherapy, Intensity-Modulated 13 Cyclophosphamide 13 trametinib 12 fluorodopa F 18 12 X-Rays 12 Radiosurgery 12 Erlotinib Hydrochloride 12 Topotecan 11 Everolimus 11 Magnetic Resonance Imaging 10 IL13-PE38 10 dabrafenib 9 Etoposide 9 Drug Therapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × pamiparib × Clear all

NCT03749187 2026-03-13

PNOC017

University of California, San Francisco

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡